Gentex Corp
GNTX
ISIN null / Valor 933761
Gentex Corp
UMushroom community rating:
About company
Gentex Corporation, originally a custom helmet manufacturer, transitioned to designing and manufacturing aircrew respiratory products after being acquired by Protection, Inc. in 1969. The company's core competency expanded to include hearing protection and communication systems through acquisitions and organic investments, with a focus on providing solutions for defense, emergency response, and industrial safety customers. Gentex Corporation continues to lead globally in the design and manufacture of oxygen masks, chemical and biological respirators, as well as hearing protection and communication products. The company's commitment to R&D has led to the development of innovative passive and active noise reduction technologies, enhancing situational awareness and speech intelligibility for its customers.
Summarized from source with an LLMView SourceSector: Consumer CyclicalsLatest Results (13.05.2026):
Gentex Corp — Fourth Quarter 2025: Gentex reported consolidated fourth-quarter 2025 net sales of $644.4 million and consolidated net income attributable to Gentex of about $93.0 million (diluted EPS $0.43). For calendar year 2025 the company reported consolidated net sales of $2.53 billion, consolidated net income attributable to Gentex of $384.8 million (diluted EPS $1.74), and returned $425.9 million to shareholders through repurchases and dividends.
Quarter revenue & profit
Q4 2025 consolidated net sales: $644.4M; Core Gentex (ex-VOXX) net sales: $541.0M. Q4 consolidated income from operations: $120.1M. Q4 consolidated net income attributable to Gentex: ~$93.0M; diluted EPS: $0.43.
Full-year results (2025)
Calendar-year 2025 consolidated net sales: $2.53B (Core Gentex ex-VOXX: $2.27B). Consolidated income from operations: $473.9M. Consolidated net income attributable to Gentex: $384.8M; diluted EPS: $1.74.
Margins and drivers
Q4 consolidated gross margin: 34.8%; Core Gentex gross margin: 35.5% (300 bps improvement vs. Q4 2024). FY 2025 consolidated gross margin: 34.2%; Core 34.7% (140 bps improvement vs. FY 2024). Management cited favorable product mix, operational efficiencies and purchasing cost reductions; tariff-related costs reduced Q4 gross margin by ~150 bps (net of recoveries).
Capital allocation & buybacks
Capital returned to shareholders in 2025: $425.9M (up 35% vs. 2024) including $319.0M in share repurchases (13.6M shares) and $106.9M in dividends. The company also repurchased 3.8M shares in Q4 2025.
Acquisition (VOXX) impact
Gentex completed the VOXX acquisition in April 2025. VOXX contributed ~$103.4M of revenue in Q4 and ~$267.2M for the full year; financials are shown consolidated and with Core Gentex (ex-VOXX) supplemental disclosure.
Shipments & volume trends
Auto-dimming mirror shipments: Q4 2025 — 10,462 thousand units (down ~3% year-over-year); FY 2025 — 44,825 thousand units (down ~6% y/y), reflecting lower vehicle production/volume in several markets.
Non-GAAP adjustments & tax
Adjusted (non-GAAP) income from operations for FY 2025: $492.3M; adjusted diluted EPS: $1.81. Effective tax rate Q4 2025: 16.3% (vs. 10.3% Q4 2024); FY 2025 effective tax rate: 16.6% (vs. 14.3% in 2024), driven by reduced stock‑based compensation tax benefits and lower FDII deduction.
Balance sheet highlights
Total assets at year-end: $2.9286B. Cash and cash equivalents: $145.6M (down from $233.3M year‑ago). Inventories and receivables increased (inventories $516.3M; AR $368.5M), reflecting integration and working capital dynamics following VOXX.
2026 guidance & outlook
2026 guidance notes: expected consolidated gross margin 34%–35%, estimated annual tax rate 16%–18%, and light‑vehicle production assumptions aligned to S&P Global Mobility mid‑January 2026 forecast. Management flagged ongoing cost improvement initiatives and uncertainty from tariffs and vehicle production trends.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
5245 M
Market cap (USD)
2,256,632
Daily traded volume (Shares)
28.92 / 28.57
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
